Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-03-24 5:01 pm Purchase |
2025-03-21 | 13G | electroCore, Inc. ECOR |
Theofilos Charles Steve | 444,530 6.200% |
25,817 (+6.17%) |
Filing History |
| 2024-10-25 4:30 pm Purchase |
2024-10-18 | 13G | TuHURA Biosciences, Inc. HURA |
Theofilos Charles Steve | 2,506,321 5.900% |
2,506,321 (New Position) |
Filing History |
| 2024-06-18 4:15 pm Purchase |
2024-05-31 | 13D | Akari Therapeutics, Plc AKTX |
Theofilos Charles Steve | 2,370,750,000 9.990% |
2,370,750,000 (New Position) |
Filing History |
| 2024-06-07 4:33 pm Sale |
2024-06-05 | 13D | electroCore, Inc. ECOR |
Theofilos Charles Steve | 418,713 6.500% |
-219,220 (-34.36%) |
Filing History |
| 2023-12-18 4:10 pm Unchanged |
2023-12-08 | 13D | electroCore, Inc. ECOR |
Theofilos Charles Steve | 637,933 9.900% |
0 (Unchanged) |
Filing History |
| 2023-12-07 07:53 am Purchase |
2023-12-04 | 13G | electroCore, Inc. ECOR |
Theofilos Charles Steve | 637,933 9.900% |
637,933 (New Position) |
Filing History |